A clinical study on Nimba panchanga chooranam(internal) for Vitiligo

Phase-II Non Randomized clinical study on Venpulli(vitiligo) with the evaluation of Siddha trial drug Nimba panchanga chooranam(internal) in children - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085999

Enrollment

Registered

2025-04-30

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Nimba panchanga chooranam(internal): Nimba panchanga chooranam 975mg-1.95g twice a day with honey for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Hypo-pigmented patches surrounded by hyperpigmented border present in any part of the body

Exclusion criteria

Exclusion criteria: Albinism Piebaldsim Hypo pigmented patches starts firstly at lips, genital area Depigmented patches occurred after burns Juvenile diabetes with Vitiligo

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduction of VASI ScoreTimepoint: 48 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr M Koteswari

Government siddha medical college Chennai

mahema.siddha@gmail.com9894325360

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026